We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$384B
AUM Growth
+$26.1B
Cap. Flow
+$10.6B
Cap. Flow %
2.75%
Top 10 Hldgs %
14.05%
Holding
4,364
New
89
Increased
2,019
Reduced
1,841
Closed
107

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.02B
2
MSFT icon
Microsoft
MSFT
+$337M
3
AAPL icon
Apple
AAPL
+$308M
4
META icon
Meta Platforms (Facebook)
META
+$222M
5
AMZN icon
Amazon
AMZN
+$218M

Sector Composition

Rank Sector Weight
1 Financials 15.39%
2 Technology 14.36%
3 Healthcare 12.87%
4 Industrials 10.7%
5 Consumer Discretionary 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZSAN
4001
DELISTED
Zosano Pharma Corporation
ZSAN
$65K ﹤0.01%
113
CATX icon
4002
Perspective Therapeutics
CATX
$335M
$64K ﹤0.01%
12,458
PFX icon
4003
PhenixFIN
PFX
$89.2M
$63K ﹤0.01%
+526
New +$65.2K
SIF icon
4004
SIFCO Industries
SIF
$169M
$63K ﹤0.01%
11,080
-200
-2% -$1.24K
GFN
4005
DELISTED
General Finance Corporation
GFN
$62K ﹤0.01%
12,122
+2,062
+20% +$10K
ATNM icon
4006
Actinium Pharmaceuticals
ATNM
$23.5M
$61K ﹤0.01%
3,546
VNRX icon
4007
VolitionRx Ltd
VNRX
$9.58M
$60K ﹤0.01%
1,136
VIRX
4008
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$60K ﹤0.01%
881
+1
+0.1% +$82
REXX
4009
DELISTED
Rex Energy Corporation
REXX
$60K ﹤0.01%
22,122
-41
-0.2% -$106
FLNA
4010
Filana Therapeutics
FLNA
$46.4M
$59K ﹤0.01%
14,636
+800
+6% +$2.86K
BIOL
4011
DELISTED
Biolase, Inc.
BIOL
$59K ﹤0.01%
8
VISL
4012
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$59K ﹤0.01%
31
+18
+138% +$41.4K
EMMS
4013
DELISTED
Emmis Communications Corp
EMMS
$58K ﹤0.01%
18,448
-1,035
-5% -$2.75K
GTIM icon
4014
Good Times Restaurants
GTIM
$15M
$57K ﹤0.01%
21,131
HEPA
4015
DELISTED
Hepion Pharmaceuticals
HEPA
0
INFU icon
4016
InfuSystem Holdings
INFU
$245M
$57K ﹤0.01%
27,821
WAC
4017
DELISTED
Walter Investment Mgt Corp
WAC
$57K ﹤0.01%
94,883
-355
-0.4% -$206
AUMN
4018
DELISTED
Golden Minerals Company
AUMN
$56K ﹤0.01%
4,694
DEST
4019
DELISTED
Destination Maternity Corporation
DEST
$56K ﹤0.01%
33,827
-644
-2% -$1.17K
OREX
4020
DELISTED
Orexigen Therapeutics, Inc.
OREX
$56K ﹤0.01%
26,373
+106
+0.4% +$259
CASI
4021
DELISTED
CASI Pharmaceuticals
CASI
$55K ﹤0.01%
3,103
GROW icon
4022
US Global Investors
GROW
$37.8M
$55K ﹤0.01%
25,946
-200
-0.8% -$297
KSPN
4023
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$54K ﹤0.01%
1,342
-54
-4% -$1.99K
AMPE
4024
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$53K ﹤0.01%
291
CAPR icon
4025
Capricor Therapeutics
CAPR
$228M
$52K ﹤0.01%
1,709

Similar funds

Northern Trust's Q3 2017 Portfolio in Review

As of Q3 2017, Northern Trust held 4,364 positions worth $384B, up 7.3% from $358B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 4.5%. Northern Trust opened 89 new positions and exited 107, leaving the 4,364-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Northern Trust's largest Q3 2017 buy was Baker Hughes: 5,053,073 shares worth $185M.
  • Northern Trust added most to DuPont de Nemours in Q3 2017, an estimated $1.02B increase.
  • Northern Trust's biggest Q3 2017 reduction was FlexShares STOXX Global Broad Infrastructure Index Fund, cutting an estimated $73.5M.
  • Northern Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $886M.
  • Northern Trust's ten largest holdings make up 14% of its $384B portfolio in Q3 2017.
  • Northern Trust opened 89 new positions and closed 107 in Q3 2017.
  • Northern Trust's portfolio value rose 7.3% quarter-over-quarter to $384B.

Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.